This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Infectious disease-focused Chembio Diagnostics Inc. netted $15mm through a registered public offering of 2.37mm common shares at $6.75. Chembio will use the proceeds to fund its proposed $5.5mm acquisition of opTricon, an OEM offering handheld analyzers for rapid diagnostic tests. Additional funds will help broaden US manufacturing automation and expanding and improving facilities.
In Vitro Diagnostics
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?